Objective: Cell proliferation and gene expression regulation were studied in human fetal epiphyseal chondrocytes to ascertain the involvement of GH-IGF axis components in human fetal growth regulation by 1,25-dihydroxyvitamin D-3 (VitD) and growth hormone (GH). Design: Chondrocytes from primary cultures were plated in serum-free medium for 48 h and incubated for a further 48 h with VitD (10(-11) to 10(-6) M) and/or IGF-I (100 ng/ml) and/or GH (500 ng/ml). We analyzed H-3-thymidine incorporation into DNA and IGF-I, IMP-3, GHR, SOX9, COL2A1, aggrecan and COMP gene expression by real-time quantitative PCR. Results: VitD dose-dependently and significantly inhibited H-3-thymidine incorporation whereas GH had no effect on proliferation and, when combined with VitD, the same inhibition was observed as with VitD alone. IGF-I (100 ng/ml) significantly stimulated proliferation and opposed inhibition by VitD. VitD dose-dependently stimulated IGF-I (11.1 +/- 19.8 at VitD 10(-6) M), IGFBP-3 (2.6 +/- 0.9), GHR (3.8 +/- 2.8) and COMP (1.5 +/- 0.6) expression whereas it inhibited SOX9 (0.7 +/- 0.2), COL2A1 (0.6 +/- 0.3) and aggrecan (0.6 +/- 0.2) expression and had no significant effect on IGF-II. IGF-I stimulated IGF-I, IGFBP-3, SOX9, COL2A1 and aggrecan expression and opposed COL2A1 and aggrecan gene expression inhibition by VitD. GH alone had no effect on gene expression whereas, in the presence of VitD, significantly-increased IGF-I expression stimulation was observed above values obtained with VitD alone (17.5 +/- 7.4). Conclusions: Our results suggest that VitD regulation of fetal growth cartilage could have consisted of parallel enhancing of cell differentiation and conditioning to a phenotype more sensitive to regulation by other hormones such as GH as shown by increased GHR and IGF-I expression, but not by IGF-II expression which was not regulated. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:232 / 237
页数:6
相关论文
共 46 条
[1]
BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O